GSK Glaxosmithkline plc - ADR
9,209
$44.58
$0.01
(0.02%)
| Watchers | 9,209 |
| 52-Wk Low | $33.33 |
| 52-Wk High | $45.93 |
| Market Cap | $90.92B |
| Volume | 1.67M |
| 52-Wk High | $45.93 |
| 52-Wk Low | $33.33 |
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data ShowsBenzinga • about 4 hours ago
GSK announced results from phase 3 trials SWIFT-1 and SWIFT-2, showing depemokimab's efficacy and safety in reducing severe asthma exacerbations.
read more...
Share to Feed
A vaccine breakthrough helped Walmsley after Elliot's argued in 2021 that Britain's oldest drugmaker had lost its way. Read More...
GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advil painkillers.
read more...
Futures Flat In Quiet End To Torrid Week
US equity futures are flat to end a torrid week which saw all indexes hit a fresh all-time high while the terminally anachronistic Dow Jones...
:max_bytes(150000):strip_icc()/GettyImages-1493093301-4af383e124cf49858117a9b3c98556f5.jpg)
Bo Shen / Getty Images
Key TakeawaysThe S&P 500 finished flat on Monday, May 13, 2024, amid concerns about rising prices ahead of inflation data due later in the week.Incyte shares jumped higher...
Amazon's 1.2 billion investment marks a significant stride in bolstering its French presence, promising 3,000 new jobs. The move aligns with France's push for tech investment, showcased at the...
FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.
read more...
Future Slide In Damp Start To New Month As Fed Decision Looms
US equities were set for a second day of losses, as investors weighed disappointing tech earnings and braced for today's...
The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others...